Merging CRISPR Editing and single cell sequencing technologies
Keynote address by the Novartis Institutes for Biomedical Reseach
SMi's conference on 3D Cell Culture will take place on 21st and 22nd February 2018 in London UK and feature a keynote address from Max Salick, Postdoctoral Researcher, Novartis Institutes for Biomedical Research.
MERGING CRISPR-EDITING AND SINGLE CELL SEQUENCING TECHNOLOGIES TO UNCOVER THE BIOLOGY OF HUMAN NEURODEVELOPMENTAL DISEASES IN 3D: CASE STUDIES WITH ZIKA VIRUS AND TUBEROUS SCLEROSIS
Max Salick, Postdoctoral Researcher, Novartis Institutes For Biomedical Research
Further details available at http://www.3d-CellCulture.com/3Dnet